OPHTHALMIC IMAGING SYSTEMS CONTACTS:
GIL ALLON, CEO
221 LATHROP WAY, SUITE I ARIEL SHENHAR, CFO
SACRAMENTO, CA 95815 (916) 646-2020
INVESTOR RELATIONS
TODD FROMER / GARTH RUSSELL
KCSA Worldwide
212-896-1215 / 212-896-1250
FOR IMMEDIATE RELEASE
---------------------
MEDIVISION SELLS 310,000 SHARES OF
OPHTHALMIC IMAGING SYSTEMS' COMMON STOCK
SACRAMENTO, Calif., December 20, 2005 -- Ophthalmic Imaging Systems (OTCBB:OISI)
(OIS), a leading provider of ophthalmic digital imaging systems, announced today
that MediVision Medical Imaging Ltd., its major shareholder, sold 310,000 shares
of OIS's common stock to the clients of an institutional investor at the price
per share of $1.45. As a result of this sale, the public float increases to
approximately 5.1 million shares.
The institution manages separate accounts and a micro-cap value partnership,
which primarily invests in micro-cap U.S. stocks with market capitalization less
than $300 million. The institution pursues a long-term buy-and-hold strategy
with its investments.
Gil Allon, Chief Executive Officer of Ophthalmic Imaging Systems, said, "I am
pleased to announce MediVision's sale of OIS shares to another institutional
investor. This is one more example of OIS management and MediVision's commitment
to introducing new institutional investors to the OIS story and increase the
Company's liquidity. MediVision has specifically targeted long-term investors
that possess a solid knowledge of micro- and small-cap equities. We recognize
the importance of increasing the awareness of OIS to the investment community as
the Company continues to grow. We believe that by increasing OIS' liquidity
combined with its continued strong financial performance, OIS shares will reach
a higher valuations."
About Ophthalmic Imaging Systems
Ophthalmic Imaging Systems, a majority-owned subsidiary of MediVision, is the
leading provider of ophthalmic digital imaging systems. The Company designs,
develops, manufactures and markets digital imaging systems and informatics
solutions for the eye care market. With over twenty years in the ophthalmic
imaging business, the Company has consistently introduced new, innovative
technology. The Company, together with MediVision, co-market and support their
products through an extensive network of dealers, distributors, and direct
representatives.
Statements in this press release which are not historical data are
forward-looking statements which involve known and unknown risks, uncertainties,
or other factors not under the Company's control, which may cause actual
results, performance, or achievements of the Company to be materially different
from the results, performance, or other expectations implied by these
forward-looking statements. These factors include, but are not limited to, those
detailed in the Company's periodic filings with the Securities and Exchange
Commission.